Adherence to metformin in adults with type 2 diabetes: a combined method approach

References

• Royal Pharmaceutical Society Medicine optimisation: Helping patient to make the most of medicine. 2013. https://www.rpharms.com/promoting-pharmacy-pdfs/mo---evidence-in-practice.pdf. Accessed 26 May 2016
   Google Scholar
• American Diabetes Association (ADA). 6. Glycemic targets: standards of medical care in diabetes—2018. Diabetes Care. 2018;41:S55–S64. https://doi.org/10.2337/dc18-S006.
   PubMed Web of Science ®Google Scholar
• National Institute for Health and Clinical Excellence. Managing blood glucose in adults with type 2 diabetes. 2019a. https://pathways.nice.org.uk/pathways/type-2-diabetes-in-adults/managing-blood-glucose-in-adults-with-type-2-diabetes. Accessed 25 Sep 2019.
   Google Scholar
• Krass I, Schieback P, Dhippayom T. Adherence to diabetes medication: a systematic review. Diabet Med. 2015;32:725–737. https://doi.org/10.1111/dme.12651.
   PubMed Web of Science ®Google Scholar
• Egede LE, Gebregziabher M, Echols C, Lynch CP. Longitudinal effects of medication nonadherence on glycemic control. Ann Pharmacother. 2014;48:562–570.
   PubMed Web of Science ®Google Scholar
• Khunti K, Seidu S, Kunutsor S, Davies M. Association between adherence to pharmacotherapy and outcomes in type 2 diabetes: a meta-analysis. Diabetes Care. 2017;40:1588–1596. https://doi.org/10.2337/dc16-1925.
   PubMed Web of Science ®Google Scholar
• , Rodgers LR, Weedon MN, Henley WE, Hattersley AT, Shields BM. Cohort profile for the MASTERMIND study: using the Clinical Practice Research Datalink (CPRD) to investigate stratification of response to treatment in patients with type 2 diabetes. BMJ Open. 2017;7:e017989. https://doi.org/10.1136/bmjopen-2017-017989.
   Web of Science ®Google Scholar
• García-Pérez LE, Alvarez M, Dilla T, Gil-Guillén V, Orozco-Beltrán D. Adherence to therapies in patients with type 2 diabetes. Diabetes Ther. 2013;4:175–194. https://doi.org/10.1007/s13300-013-0034-y.
   PubMed Web of Science ®Google Scholar
• Capoccia K, Odegard P, Letassy N. Medication adherence with diabetes medication a systematic review of the literature. Diabetes Educ. 2016;42:34–71.
   PubMed Web of Science ®Google Scholar
• McGovern A, Tippu Z, Hinton W, Munro N, Whyte M, de Lusignan S. Comparison of medication adherence and persistence in type 2 diabetes: a systematic review and meta-analysis. Diabetes Obes Metab. 2018;20:1040–1043.
   PubMed Web of Science ®Google Scholar
• Shenolikar RA, Balkrishnan R, Camacho FT, Whitmire JT, Anderson RT. Race and medication adherence in medicaid enrollees with type-2 diabetes. J Natl Med Assoc. 2006;98:1071–1077.
   PubMed Web of Science ®Google Scholar
• Haupt D, Weitoft GR, Nilsson JL. Refill adherence to oral antihyperglycaemic drugs in Sweden. Acta Diabetol. 2009;46:203–208. https://doi.org/10.1007/s00592-008-0076-1.
   PubMed Web of Science ®Google Scholar
• White AJ, Kellar I, Prevost AT, Kinmonth AL, Sutton S, Canny M, Griffin SJ. Adherence to hypoglycaemic medication among people with type 2 diabetes in primary care. Prim Care Diabetes. 2012;6:27–33.
   PubMed Web of Science ®Google Scholar
• Quilliam BJ, Ozbay AB, Sill BE, Kogut SJ. The association between adherence to oral anti-diabetic drugs and hypoglycaemia in persons with type 2 diabetes. Diabet Med. 2013;30:1305–1313.
   PubMed Web of Science ®Google Scholar
• Lee CS, Tan J, Sankari U, Koh Y, Tan NC. Assessing oral medication adherence among patients with type 2 diabetes mellitus treated with polytherapy in a developed Asian community: a cross-sectional study. BMJ Open. 2017;7:e016317. https://doi.org/10.1136/bmjopen-2017-016317.
   Web of Science ®Google Scholar
• Martono D, Hak E, Heerspink H, Wiffert B, Denig P. Predictors of HbA1c levels in patient initiating metformin. Curr Med Res Opin. 2016;32:2021–2028.
   PubMed Web of Science ®Google Scholar
• Farmer AJ, Rodgers LR, Lonergan M, Shields B, Weedon MN, Donnelly L, Holman RR, Pearson ER, Hattersley AT. Adherence to oral glucose-lowering therapies and associations with 1-year HbA1c: a retrospective cohort analysis in a large primary care database. Diabetes Care. 2016;39:258–263. https://doi.org/10.2337/dc15-1194.
   PubMed Web of Science ®Google Scholar
• Min JY, Griffin MR, Chipman J, Hackstadt AJ, Greevy RA, Grijalva CG, Hung AM, Roumie CL. Recent metformin adherence and the risk of hypoglycaemia in the year following intensification with a sulfonylurea. Diabet Med. 2019;36:482–490. https://doi.org/10.1111/dme.13853.
   PubMed Web of Science ®Google Scholar
• Nunes V, Neilson J, O’Flynn N, Calvert N, Kuntze S, Smithson H, Benson J, Blair J, Bowser A, Clyne W, C Crome P, Haddad P, Hemingway S, Horne R, Johnson S, Kelly S, Packham B, Patel M, Steel J. Clinical guidelines and evidence review for medicines adherence: involving patients in decisions about prescribed medicines and supporting adherence. London: National Collaborating Centre for Primary Care and Royal College of General Practitioners. 2009. https://www.nice.org.uk/guidance/cg76. Accessed 1 Mar 2017.
   Google Scholar
• Lehmann A, Aslani P, Ahmed R, Celio J, Gauchet A, Bedouch P, Bugnon O, Allenet B, Schneider MP. Assessing medication adherence: options to consider. Int J Clin Pharm. 2013. https://doi.org/10.1007/s11096-013-9865-x.
   PubMed Web of Science ®Google Scholar
• Shah N, Hawwa A, Millership J, Collier P, Ho P, Tan M, Peake D, Tirupathi S, Bothwell J, Bailie N, Shepherd C, Craig J, McElnay JC. Adherence to antiepileptic medicines in children: a multiple-methods assessment involving dried blood spot sampling. Epilepsia. 2013;54:1020–1027.
   PubMed Web of Science ®Google Scholar
• AbuRuz S, Millership J, McElnay J. Dried blood spot liquid chromatography assay for therapeutic drug monitoring of metformin. J Chromatogr B. 2006;832:202–207.
   PubMed Web of Science ®Google Scholar
• McDade TW, Williams S, Snodgrass JJ. What a drop can do: dried blood spots as a minimally invasive method for integrating biomarkers into population-based research. Demography. 2007;44:899–925.
   PubMed Web of Science ®Google Scholar
• Suyagh M, Collier PS, Millership JS, Iheagwaram G, Millar M, Halliday HL, McElnay JC. Metronidazole population pharmacokinetics in preterm neonates using dried blood-spot sampling. Pediatrics. 2011;127:e367–734.
   PubMed Web of Science ®Google Scholar
• Li P, Lee M, editors. Dried blood spots applications and techniques. Wiley Series on Pharmaceutical Science. Hoboken: John Wiley Sons Inc; 2014.
   Google Scholar
• Hawwa AF, AlBawab A, Rooney M, Wedderburn LR, Beresford MW, McElnay JC. Methotrexate polyglutamates as a potential marker of adherence to long-term therapy in children with juvenile idiopathic arthritis and juvenile dermatomyositis: an observational, cross-sectional study. Arthritis Res Ther. 2015;17:295. https://doi.org/10.1186/s13075-015-0814-z.
   PubMed Web of Science ®Google Scholar
• Ette EI, Williams PJ. Population pharmacokinetics I: background, concepts, and models. Ann Pharmacother. 2004;38:1702–1706.
   PubMed Web of Science ®Google Scholar
• Mould DR, Upton RN. Basic concepts in population modeling, simulation, and model-based drug development. CPT Pharmacometrics Syst Pharmacol. 2012;1: e6. https://doi.org/10.1038/psp.2012.4.
   PubMedGoogle Scholar
• Bonate PL. Pharmacokinetic-pharmacodynamic modelling and simulation. New York: Springer; 2006.
   Google Scholar
• Charles B. Population pharmacokinetics: an overview. Aust Prescr. 2014;37:210–213.
   Google Scholar
• Zhang C, Denti P, van der Walt JS, Ren Y, Smith P, Karlsson MO, McIlleron H. Population pharmacokinetic model for adherence evaluation using lamivudine concentration monitoring. Ther Drug Monit. 2012;34:481–484.
   PubMed Web of Science ®Google Scholar
• Almardini R, Taybeh EO, Alsous MM, Hawwa AF, McKeever K, Horne R, McElnay JC. A multiple methods approach to determine adherence with prescribed mycophenolate in children with kidney transplant. Br J Clin Pharmacol. 2019;85:1434–1442.
   PubMed Web of Science ®Google Scholar
• Daniel WW, Cross CL. Biostatistics: a Foundation for Analysis in the Health Sciences. 10th ed. New York: John Wiley & Sons; 2013.
   Google Scholar
• Horne R, Weinman J. Self-regulation and self-management in asthma: exploring the role of illness perceptions and treatment beliefs in explaining non-adherence to preventer medication. Psychol Health. 2002;17:17–32.
   Web of Science ®Google Scholar
• Horne R, Weinman J. Patients’ beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res. 1999;47:555–567.
   PubMed Web of Science ®Google Scholar
• Radloff LS. The CES-D scale a Self-Report Depression Scale for research in the general population. Appl Psychol Meas. 1977;1:385–401.
   Web of Science ®Google Scholar
• Vluggen S, Hoving C, Schaper NC, De Vries H. Psychological predictors of adherence to oral hypoglycaemic agents: an application of the ProMAS questionnaire. Psychol Health. 2020;35:387–404. https://doi.org/10.1080/08870446.2019.1672873.
   PubMed Web of Science ®Google Scholar
• Bardin C, Nobecourt E, Larger E, Chast F, Treluyer JM, Urien S. Population pharmacokinetics of metformin in obese and non-obese patients with type 2 diabetes mellitus. Eur J Clin Pharmacol. 2012;68:961–968.
   PubMed Web of Science ®Google Scholar
• Duong JK, Kumar SS, Kirkpatrick CM, Greenup LC, Arora M, Lee TC, Timmins P, Graham GG, Furlong TJ, Greenfield JR, Williams KM, Day RO. Population pharmacokinetics of metformin in healthy subjects and patients with type 2 diabetes mellitus: simulation of doses according to renal function. Clin Pharmacokinet. 2013;52:373–384.
   PubMed Web of Science ®Google Scholar
• The International Association of Forensic Toxicologists (TIAFT).Reference blood level list of therapeutic and toxic substances. London: The Association; 1995–2015. 2004. http://www.tiaft.org. Accessed 10 Sep 2019.
   Google Scholar
• Food and Drug Administration. FDA label approved (revised) on 07/19/2013 for Metformin Hydrochloride, ANDA no. 091664. 2013. http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/091664Orig1s000lbl.pdf Accessed 12 Sep 2020.
   Google Scholar
• Kajbaf F, De Broe ME, Lalau JD. Therapeutic concentrations of metformin: a systematic review. Clin Pharmacokinet. 2016;55:439–459. https://doi.org/10.1007/s40262-015-0323-x.
   PubMed Web of Science ®Google Scholar
• Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33:159–174.
   PubMed Web of Science ®Google Scholar
• Paschal AM, Hawley SR, St Romain T, Ablah E. Measures of adherence to epilepsy treatment: review of present practices and recommendations for future directions. Epilepsia. 2008;49:1115–1122. https://doi.org/10.1111/j.1528-1167.2008.01645.x.
   PubMed Web of Science ®Google Scholar
• Barranco Garduno LM, Neri Salvador JC, Juarez Olguin H, Lugo Goytia G, Carrasco Portugal M, Flores MF. Population pharmacokinetics of metformin in Mexican patients with type 2 diabetes mellitus. Int J Pharmacol. 2015;11:632–637.
   Google Scholar
• British National Formulary (BNF). 2019. https://www.pharmpress.com/assets/docs/bnf%2077_9780857113436.pdf
   Google Scholar
• Culig J, Leppée M. From Morisky to Hill-bone; self-reports scales for measuring adherence to medication. Coll Antropol. 2014;38:55–62.
   PubMedGoogle Scholar
• Lam WY, Fresco P. Medication adherence measures: an overview. Biomed Res Int. 2015. https://doi.org/10.1155/2015/217047.
   Web of Science ®Google Scholar
• Osterberg L, Blaschke T. Adherence to medication. N Eng J Med. 2005;353:487–497.
   PubMed Web of Science ®Google Scholar
• Jimmy B, Jose J. Patient medication adherence: measures in daily practice. Oman Med J. 2011;26:155–159.
   PubMedGoogle Scholar
• Brown MT, Sinsky CA. Medication adherence: we didn’t ask and they didn’t tell. 2013. https://www.aafp.org/fpm/2013/0300/fpm20130300p25.pdf . Accessed 15 May 2019.
   Google Scholar
• Winkler A, Teuscher AU, Mueller B, Diem P. Monitoring adherence to prescribed medication in type 2 diabetic patients treated with sulfonylureas. Swiss Med Wkly. 2002;132:379–385.
   PubMed Web of Science ®Google Scholar
• Driscoll KA, Wang Y, Johnson SB, Gill E, Wright N, Deeb LC. White coat adherence occurs in adolescents with type 1 diabetes receiving intervention to improve insulin pump adherence behaviors. J Diabetes Sci Technol. 2017;11:455–460. https://doi.org/10.1177/1932296816672691.
   PubMedGoogle Scholar
• McConville A, Noser AE, Clements MA, Patton SR. Mealtime insulin BOLUS score increases prior to clinic visits in youth with type 1 diabetes. BMJ Open Diabetes Res Care. 2020;8: e001348. https://doi.org/10.1136/bmjdrc-2020-001348.
   PubMed Web of Science ®Google Scholar
• Chong E, Wang H, King-Shier KM, Quan H, Rabi DM, Khan NA. Prescribing patterns and adherence to medication among South-Asian, Chinese and white people with type 2 diabetes mellitus: a population-based cohort study. Diabet Med. 2014;31:1586–1593. https://doi.org/10.1111/dme.12559.
   PubMed Web of Science ®Google Scholar
• Horsburgh S, Barson D, Zeng J, Sharples K, Parkin L. Adherence to metformin monotherapy in people with type 2 diabetes mellitus in New Zealand. Diabetes Res Clin Pract. 2019;158: 107902. https://doi.org/10.1016/j.diabres.2019.107902.
   PubMed Web of Science ®Google Scholar
• Mateo JF, Gil-Guillen VF, Mateo E, Orozco D, Carbayo JA, Merino J. Multifactorial approach and adherence to prescribed oral medications in patients with type 2 diabetes. Int J Clin Pract. 2006;60:422–428.
   PubMed Web of Science ®Google Scholar
• Tiv M, Viel JF, Mauny F, Eschwège E, Weill A, Fournier C, Fagot-Campagna A, Penfornis A. Medication adherence in type 2 diabetes: the ENTRED study 2007, a French Population-Based Study. PLoS ONE. 2012;7: e32412. https://doi.org/10.1371/journal.pone.0032412.
   PubMed Web of Science ®Google Scholar
• McAdam-Marx C, Bellows BK, Unni S, Wygant G, Mukherjee J, Ye X, Brixner DI. Impact of adherence and weight loss on glycemic control in patients with type 2 diabetes: cohort analyses of integrated medical record, pharmacy claims, and patient-reported data. J Manag Care Spec Pharm. 2014;20:691–700.
   PubMed Web of Science ®Google Scholar
• Gordon J, McEwan P, Idris I, Evans M, Puelles J. Treatment choice, medication adherence and glycemic efficacy in people with type 2 diabetes: a UK clinical practice database study. BMJ Open Diabetes Res Care. 2018;6: e000512. https://doi.org/10.1136/bmjdrc-2018-000512.
   PubMed Web of Science ®Google Scholar
• Kirkman MS, Rowan-Martin MT, Levin Fonseca VA, Schmittdiel JA, Herman WA, Aubert RE. Determinants of adherence to diabetes medications: findings from a large pharmacy claims database. Diabetes Care. 2015;38(4):604–609.
   PubMed Web of Science ®Google Scholar
• Michie S, van Stralen MM, West R. The behaviour change wheel: a new method for characterising and designing behaviour change interventions. Implement Sci. 2011;6:42. https://doi.org/10.1186/1748-5908-6-42.
   PubMed Web of Science ®Google Scholar
• Boeni F, Spinatsch E, Suter K, Hersberger KE, Arnet I. Effect of drug reminder packaging on medication adherence: a systematic review revealing research gaps. Syst Rev. 2014;3:29–29. https://doi.org/10.1186/2046-4053-3-29.
   PubMedGoogle Scholar
• Bartlett Ellis RJ, Knisely MR, Boyer K, Pike C. Pillbox intervention fidelity in medication adherence research: a systematic review. Nurs Outlook. 2017;65(4):464–476. https://doi.org/10.1016/j.outlook.2016.12.011.
   PubMed Web of Science ®Google Scholar
• Conn VS, Ruppar TM, Chan KC, Dunbar-Jacob J, Pepper GA, De Geest S. Packaging interventions to increase medication adherence: systematic review and meta-analysis. Curr Med Res Opin. 2015;31:145–160. https://doi.org/10.1185/03007995.2014.978939.
   PubMed Web of Science ®Google Scholar
• Schwartz JK. Pillbox use, satisfaction, and effectiveness among persons with chronic health conditions. Assistive Technol. 2017;29(4):181–187. https://doi.org/10.1080/10400435.2016.1219884.
   PubMed Web of Science ®Google Scholar
• Morello CM, Chynoweth M, Kim H, Singh RF, Hirsch JD. Strategies to improve medication adherence reported by diabetes patients and caregivers: results of a taking control of your diabetes survey. Ann Pharmacother. 2011;45(2):145–153. https://doi.org/10.1345/aph.1P322.
   PubMed Web of Science ®Google Scholar
• Aikens JE, Piette JD. Longitudinal association between medication adherence and glycaemic control in type 2 diabetes. Diabet Med. 2013;30:338–344.
   PubMed Web of Science ®Google Scholar
• Polonsky WH, Henry RR. Poor medication adherence in type 2 diabetes: recognizing the scope of the problem and its key contributors. Patient Prefer Adherence. 2016;10:1299–1307. https://doi.org/10.2147/PPA.S106821.
   PubMed Web of Science ®Google Scholar
• Hoogendoorn CJ, Shapira A, Roy JF, Walker EA, Cohen HW, Gonzalez JS. Depressive symptom dimensions and medication non-adherence in suboptimally controlled type 2 diabetes. J Diabetes Complic. 2019;33:217–222. https://doi.org/10.1016/j.jdiacomp.2018.12.001.
   PubMed Web of Science ®Google Scholar
• Mendesa R, Martins S, Fernandes L. Adherence to medication, physical activity and diet in older adults with diabetes: its association with cognition, anxiety and depression. J Clin Med Res. 2019;11:583–592.
   PubMedGoogle Scholar
• Vieira JFF, Santos P. Medication adherence in type 2 diabetes mellitus patients: a cross-sectional study. Rev Port Med Geral Fam.. 2020;36:104–112.
   Google Scholar
• Andreoulakis E, Hyphantis T, Kandylis D, Lacovides A. Depression in diabetes mellitus: a comprehensive review. Hippokratia. 2012;16:205–214.
   PubMed Web of Science ®Google Scholar